Explore the latest in health care economics, insurance, and payment, including cost-effectiveness, value-based purchasing, and payment reform.
This cross-sectional study evaluates changes in health care affordability and prescription medication affordability during the COVID-19 pandemic (2021 and 2022) compared with pre–COVID-19 pandemic levels (2019) and whether income-based inequities changed.
This cross-sectional microsimulation analysis simulates how overall health care payments and who pays for health care would change under rate regulation, spending growth target, and single-payer health care alternatives compared with the status quo.
This survey study examines assess early changes in insurance and access to care during Medicaid unwinding among individuals with low incomes in 4 Southern states.
This economic evaluation estimates the cost of drug development by therapeutic class and trends in pharmaceutical research and development intensity in the US from 2000 to 2018.
This Viewpoint explains some ways in which the alignment of incentives between payers and clinicians in value-based care (VBC) arrangements can be interrupted and proposes a multifaceted approach to realigning incentives for drug spending within VBC contracts to better provide value-based care and improve patient outcomes.
This quality improvement study quantifies the approval rate of prior authorization for anti-vascular endothelial growth factor (VEGF) medications and assesses the clinical and administrative burden implications.
This Viewpoint explores Centers for Medicare & Medicaid Services guidance on the collection of sexual orientation and gender identity data and how these data could be used to advance health equity for LGBTQI+ people.
This economic evaluation examines the cost-effectiveness of the rheumatoid arthritis treatment sequence initiated with biosimilar disease-modifying antirheumatic drugs (DMARDs) after failure with methotrexate vs leflunomide.
This review of a scoping review analyzes the intensity and complexity of social needs interventions in randomized clinical trials and whether the trials were designed to assess the effect of individual intervention components on health outcomes.
This study evaluated the uptake of Healthcare Common Procedure Coding System code M0201 after initial implementation to inform future policy related to in-home preventive care.
This cohort study examines the Centers for Medicare & Medicaid Services star ratings in hospitals for mortality, serious complication, and readmission outcomes.
This cross-sectional study analyzes whether insurance type (private vs public) is associated with differences in receipt of outpatient specialist care among children with asthma.
This cross-sectional study examines health care expenses and financial hardship among Medicare beneficiaries with functional disability.
This randomized clinical trial investigates the effect of financial incentives added to meal replacement therapy for treatment of severe obesity among adolescents.
This cohort study estimates the association between the adoption of managed care for dental services in Florida’s Medicaid program and nontraumatic dental emergency department visits and associated charges.
This economic evaluation estimates the out-of-pocket cost savings patients could achieve if generic drugs were purchased directly from the Mark Cuban Cost Plus Drug Company rather than using their health insurance.
This Viewpoint discusses ways to ensure the proficiency of bilingual communication among health care staff in patient-clinician encounters, such as language testing and use of professional interpreters.
This cohort study examines the association of insurance status with hospital quality and receipt of guideline-compliant care among patients with head and neck cancer.
Customize your JAMA Network experience by selecting one or more topics from the list below.